Premier Alternatives

KaloCyte

Biotechnology · Baltimore, MD · Privately Held (backing)

Developer of a red blood cell substitute designed to support oxygen delivery in trauma care settings. KaloCyte is based in Baltimore, MD. It was valued at $24.7 million at its later-stage round in Jun 2025, the last priced event on record. It has raised $5.7 million across 1 recorded round; the latest was an accelerator round in Jan 2020.

PMV mark · valuation
$24.7M
Oct 2026
Priced at
its later-stage round
Jun 2025
Total raised
$5.7M
Last round
Accelerator/Incubator
Jan 2020
How much has KaloCyte raised?
$5.7Macross 1 recorded rounds · Jan 2020 – Jan 2020

Most recently, KaloCyte raised an undisclosed amount in its Accelerator/Incubator (Jan 2020).

Free account
More of KaloCyte with a free account
  • ·The complete investor list: 21 names
  • ·Watch KaloCyte: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

KaloCyte round by round

1 rounds
Jan 2020Accelerator/Incubatorundisclosed▮
+ 1 more investors · free account

How much has KaloCyte raised?

KaloCyte has raised $5.7 million in total; 1 of its rounds is on record. The most recent was an accelerator round in Jan 2020.

KaloCyte investors

21 investors are on record for KaloCyte, including Springboard Enterprises, United States Department of War, TEDCO and Johnson & Johnson Innovation - JLABS.

For fundraisers
Raising for a company like KaloCyte?

21 investors have backed KaloCyte — start your target list with the firms already writing checks in biotechnology.

See all 21 investors →

Frequently asked about KaloCyte

How much has KaloCyte raised?
KaloCyte has raised $5.7M in total across 1 recorded funding rounds.
When was KaloCyte's last funding round?
KaloCyte's most recent recorded round was Accelerator/Incubator in Jan 2020.